Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
The Society for Maternal-Fetal Medicine (SMFM) is pleased to announce Alison G. Cahill, MD, MSCI, from the University of Texas at Austin Dell Medical School, as its new president for 2026-2027. Dr. Cahill will assume the SMFM presidency today at the conclusion of the 2026 Pregnancy Meeting™. Continue Reading
A novel artificial intelligence (AI) model accurately detected the presence of placenta accreta spectrum (PAS), a dangerous pregnancy condition that often goes undetected with current screening methods, according to new research presented today at the SMFM 2026 Pregnancy Meeting. Continue Reading
The increased number of state-level abortion restrictions in the U.S. was associated with a parallel increase in maternal deaths between 2005 and 2023, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
First-time mothers who were randomized to receive a smartphone app called Baby2Home for the first year after giving birth reported significantly fewer symptoms of stress, depression, and anxiety, as well as better overall health, compared to first-time mothers who received usual postpartum care. Continue Reading
The mRNA COVID-19 vaccine is not associated with autism or other neurodevelopmental problems in children whose mothers received the vaccine immediately before or during pregnancy, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
Prescribing daily aspirin at the first prenatal visit to all pregnant patients was associated with an overall reduction in the development of severe preeclampsia, according to new research presented today at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting™. Continue Reading
Pregnant patients who stopped taking their antidepressant medication during pregnancy were almost twice as likely to experience a mental health emergency compared with pregnant patients who continued taking their prescription, according to new research presented today at the SMFM Pregnancy Meeting. Continue Reading
SMFM and its members are deeply concerned by recent developments that threaten to further weaken the public health infrastructure clinicians depend on to protect patients—especially pregnant people and their newborns. Continue Reading
Coding Tip: Remote Physiological Monitoring (RPM) The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Trisha Malisch, CCS-P, CPC, COBGC Introduction Remote Physiological Monitoring (RPM) continues to expand as an important tool in patient care management, allowing... Continue Reading
Coding Tip: Billing and Documentation for Fetal Nonstress Tests (NSTs) The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Trisha Malisch, CCS-P, CPC, COBGC; Robert Rossi, MD; Barbra Fisher, MD, PhD Introduction Fetal nonstress tests (NSTs) are one of the most frequently used... Continue Reading
In just a few weeks, SMFM will welcome experts, researchers, students, and healthcare professionals in obstetrics Marvin Williams, DOPoster Chair to the 2026 Pregnancy Meeting in Las Vegas, Nevada. I am proud to share that we have an impressive research lineup! As Dr. Allison Bryant shared... Continue Reading
By: Britton D. Rink, MD, MS, and Barton C. Staat, MD The Society for Maternal-Fetal Medicine (SMFM) recently released updated guidelines to help doctors and patients use cell-free DNA (cfDNA) screening more wisely. cfDNA screening is a blood test used during pregnancy to check for certain fetal... Continue Reading
